EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potent ferroptosis agent RSL3 induces cleavage of Pyroptosis-Specific gasdermins in Cancer cells

William G Herrick, Huong-Lan Tran, Francesca R Tomaino, Brittany Beall, Jeevan Govindharajulu, Dominic Esposito, Laura Kuhlmann, Ralph E Parchment, James H Doroshow, Apurva K Srivastava

Scientific Reports · 2025

DOI: 10.1038/s41598-025-11368-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, 2025. Verfasst von William G Herrick und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacodynamics Biomarker Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 2170…. Hauptthemen laut MEDLINE: Pyroptosis, Ferroptosis, Neoplasms, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a form of iron-dependent cell death of interest for the development of novel anti-cancer therapies. Ferroptosis research uses a process of elimination based on assumed ferroptosis-specific inducers and inhibitors; these molecules however have off-target effects and cannot provide a comprehensive picture of overlapping pathways. We investigated whether pyroptosis—a form of inflammatory cell death—is initiated in cancer cells following treatment with the ferroptosis inducer RSL3. We treated 6 cancer cell lines with RSL3 alone or in combination with inhibitors of ferroptosis (Ferrostatin-1), caspases (zVADfmk), necroptosis (Necrostatin-1), BID (BI-6C9), or STING (H-151). Biomarkers of pyroptosis and ferroptosis were assessed using our novel quantitative multiplex immunoassay. Increased secretion of pyroptosis-associated cytokines (IL-1α, IL-1β, IL-18), and gasdermin D and E (GSDMD/E) cleavage with parallel loss of respective full-length proteins—both hallmarks of pyroptosis—were recorded in 5/6 cell lines following RSL3 treatment. RSL3 cytotoxicity was blocked by Ferostatin-1; BID and STING inhibitors also prevented GSDMD/E cleavage. We conclude that the ferroptosis-inducer RSL3 triggers pyroptosis in cancer cells; further work is required to elucidate the role of mitochondria in this process. Measurement of pathway-specific protein biomarkers is therefore necessary to identify the exact mechanism of action of novel cytotoxic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisFerroptosisNeoplasmsIntracellular Signaling Peptides and ProteinsHumansCell Line, TumorPhosphate-Binding ProteinsCytokinesGasderminsCarbolines

Stichwörter der Autor:innen

CancerCytokineFerroptosisGasderminPyroptosisRSL3

Substanzen

Phosphate-Binding ProteinsRSL3 compoundGSDME protein, humanIntracellular Signaling Peptides and ProteinsGSDMD protein, humanCytokinesGasderminsCarbolines

Autor:innen und Institutionen

  • Clinical Pharmacodynamics Biomarker Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA.
  • Protein Expression Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA.
  • Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, 20892, USA.
  • Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA.
  • Clinical Pharmacodynamics Biomarker Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA. Srivastavaa4@nih.gov.

Förderung

  • National Cancer Institute

Zitieren

APA

Herrick, W. G., Tran, H. L., Tomaino, F. R., Beall, B., Govindharajulu, J., Esposito, D., Kuhlmann, L., Parchment, R. E., Doroshow, J. H., & Srivastava, A. K. (2025). Potent ferroptosis agent RSL3 induces cleavage of Pyroptosis-Specific gasdermins in Cancer cells. Scientific Reports. https://doi.org/10.1038/s41598-025-11368-1

Vancouver

Herrick WG, Tran HL, Tomaino FR, Beall B, Govindharajulu J, Esposito D, et al. Potent ferroptosis agent RSL3 induces cleavage of Pyroptosis-Specific gasdermins in Cancer cells. Scientific Reports. 2025. doi:10.1038/s41598-025-11368-1

BibTeX
@article{Herrick2025,
  author = {Herrick, William G and Tran, Huong-Lan and Tomaino, Francesca R and Beall, Brittany and Govindharajulu, Jeevan and Esposito, Dominic and Kuhlmann, Laura and Parchment, Ralph E and Doroshow, James H and Srivastava, Apurva K},
  title = {Potent ferroptosis agent RSL3 induces cleavage of Pyroptosis-Specific gasdermins in Cancer cells},
  journal = {Scientific Reports},
  year = {2025},
  doi = {10.1038/s41598-025-11368-1}
}
Kostenlos starten →